By Dhiren Patel As someone who has worked as a Behavioral therapist for children with Autism Spectrum Disorder as well as Down Syndrome, I have seen the benefits of evidence-based behavioral science applied to therapy. However, I was increasingly frustrated with the lack of technology used. Technology could have helped me better relay data and…
Author: Dhiren Patel
Artificial Intelligence in Healthcare
By Dhiren Patel Today’s Doctor and health care providers receive copious amounts of data, whether that’s from your daily activity data, your daily measurements, data from scans, DNA testing data, etc that they must go through in order to properly diagnose a patient. Sometimes there’s too much data for the doctors to consider and so…
Competing Interests in Heathcare and how the Government can help
By Dhiren Patel Right now, we are seeing the struggle we saw a few years ago in Washington over how to fix healthcare so that the quality our care is better and it’s cheaper. Now with the planned rollback of the Affordable Care Act (Obamacare & ACA), it has become a more pressing issue. The…
Advantages of Startups and Private Companies in Healthcare Disruption
We know that policy doesn’t move fast enough and that larger healthcare providers don’t have the flexibility to be agile and develop new technology that can make an immediate impact on health care. This opens up the door for Startups to innovate and provide solutions for healthcare providers that they are not tied up trying…
Solutions for Roadblocks in Healthcare Innovation
By Dhiren Patel So I touched upon some the issues facing healthcare today, now let’s talk about the positive and how we can innovate healthcare so that it is more efficient, provides better outcomes, and costs less. Technology and data can play a huge part in this, as I mentioned we have the technology to…
Issues with Healthcare in the United States Today – 2017
By Dhiren Patel Being born with a heart condition I have had a chance to see how healthcare has evolved or stagnated in innovation due to inherent risk to the bottom-line. Reducing revenue, patient risk, and pressure from big pharmaceutical companies and insurance has kept the status quo. It’s crazy to think that we can…